ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SNWV vs JNJ // GROSS PROFIT MARGIN

SANUWAVE Health Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: SNWV 6 — JNJ 5
▲ GROSS PROFIT MARGIN LEADER: SNWV
gross-margins
77.10%
gross-margins
67.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SNWV VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SNWV JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE 77.10% 67.90% +9.20 SNWV /gross-margins <GO>
Return on Invested Capital (ROIC) 67.30% 25.50% +41.80 SNWV /roic <GO>
EV/EBITDA & P/E Valuation 7.5x 18.5x -11.00 SNWV /valuation <GO>
Free Cash Flow Yield 4.27% 2.97% +1.30 SNWV /fcf-yield <GO>
Operating Margin 11.20% 34.70% -23.50 JNJ /operating-margins <GO>
Net Profit Margin 26.80% 28.50% -1.70 JNJ /net-margins <GO>
Revenue Growth (YoY) 36.30% 6.00% +30.30 SNWV /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 5.59 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 8/9 -1.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.1 62.1 -9.00 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 3.5x 23.0x -19.50 SNWV /forward-pe <GO>
Enterprise Scale & Market Cap $45.3M $662.49B -$662.45B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SNWV REV JNJ REV SNWV GROSS % JNJ GROSS % SNWV FCF JNJ FCF
FY 2025 $44.1M $94.19B 77.1% 67.9% $1.9M $19.70B
FY 2024 $32.3M $88.82B 75.9% 69.1% $2.0M $19.84B
FY 2023 $19.3M $85.16B — — -$4.5M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SNWV // BETA —
JNJ // BETA 1.08